ZIC2 Promotes Colorectal Cancer Growth and Metastasis through the TGF-β Signaling Pathway

The authors found that high ZIC2 expression was not only associated with poor prognosis, relapse-free survival and advanced metastasis but was also an independent prognostic factor in colorectal cancer patients.